Cargando…
A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers
Immunotherapy for cancer has been a focus 50 years ago. At the time, this treatment was developed prior to cloning of the cytokines, no knowledge of regulatory T-cells, and very little information that mesenchymal stem cells (MSCs) (originally colony forming unit-fibroblasts [CFU-F]) could be licens...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631157/ https://www.ncbi.nlm.nih.gov/pubmed/26568682 http://dx.doi.org/10.4137/BCBCR.S29425 |